Probenecid directly impairs activation of the canine P2X7 receptor

被引:9
作者
Bartlett, Rachael [1 ,2 ,3 ,6 ]
Stokes, Leanne [4 ]
Curtis, Stephen J. [5 ,7 ]
Curtis, Belinda L. [5 ]
Sluyter, Ronald [1 ,2 ,3 ]
机构
[1] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia
[2] Univ Wollongong, Ctr Med & Mol Biosci, Wollongong, NSW, Australia
[3] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia
[4] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England
[5] Albion Pk Vet Hosp, Albion Pk, NSW, Australia
[6] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada
[7] Compan Anim Vet Hosp, Dapto, NSW 2530, Australia
关键词
Purinergic receptor; extracellular nucleotide; probenecid; gout; monocyte; cytokine; dog; P2X(7) RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; INTERLEUKIN-1-BETA RELEASE; SEQUESTRATION; ERYTHROCYTES; ANTAGONISTS; EXPRESSION; SECRETION; CLONING; KIDNEY;
D O I
10.1080/15257770.2017.1391395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The current study aimed to determine if probenecid could directly impair the canine P2X7 receptor, a ligand-gated cation channel activated by extracellular adenosine 5'-triphosphate (ATP). Patch clamp measurements demonstrated that probenecid impairs ATP-induced inward currents in HEK-293 cells expressing canine P2X7. Flow cytometric measurements of ethidium(+) uptake into HEK-293 cells expressing canine P2X7 showed that probenecid impairs ATP-induced pore formation in a concentration-dependent manner, with a half maximal inhibitory concentration of 158 mu M. Finally, ELISA measurements revealed that probenecid impairs ATP-induced interleukin-1 beta release in dog blood. In conclusion, this study reveals that probenecid can directly impair canine P2X7 activation.
引用
收藏
页码:736 / 744
页数:9
相关论文
共 36 条
[1]   Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120 [J].
Allsopp, Rebecca C. ;
Dayl, Sudad ;
Schmid, Ralf ;
Evans, Richard J. .
SCIENTIFIC REPORTS, 2017, 7
[2]   The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease [J].
Bartlett, Rachael ;
Stokes, Leanne ;
Sluyter, Ronald .
PHARMACOLOGICAL REVIEWS, 2014, 66 (03) :638-675
[3]   EXTRACTION OF ANTIBIOTICS FROM CIRCULATION BY LIVER AND KIDNEY - EFFECT OF PROBENECID [J].
BARZA, M ;
BRUSCH, J ;
BERGERON, MG ;
KEMMOTSU, O ;
WEINSTEIN, L .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 :S86-S97
[4]   Probenecid Blocks Human P2X7 Receptor-Induced Dye Uptake via a Pannexin-1 Independent Mechanism [J].
Bhaskaracharya, Archana ;
Phuong Dao-Ung ;
Jalilian, Iman ;
Spildrejorde, Mari ;
Skarratt, Kristen K. ;
Fuller, Stephen J. ;
Sluyter, Ronald ;
Stokes, Leanne .
PLOS ONE, 2014, 9 (03)
[5]   Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567 [J].
Bhattacharya, Anindya ;
Wang, Qi ;
Ao, Hong ;
Shoblock, James R. ;
Lord, Brian ;
Aluisio, Leah ;
Fraser, Ian ;
Nepomuceno, Diane ;
Neff, Robert A. ;
Welty, Natalie ;
Lovenberg, Timothy W. ;
Bonaventure, Pascal ;
Wickenden, Alan D. ;
Letavic, Michael A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (03) :624-640
[6]   P2X7 Receptor as a Therapeutic Target [J].
De Marchi, Elena ;
Orioli, Elisa ;
Dal Ben, Diego ;
Adinolfi, Elena .
ION CHANNELS AS THERAPEUTIC TARGETS, PT B, 2016, 104 :39-79
[7]  
DIVIRGILIO F, 1988, J IMMUNOL, V140, P915
[8]   INHIBITION OF FURA-2 SEQUESTRATION AND SECRETION WITH ORGANIC ANION TRANSPORT BLOCKERS [J].
DIVIRGILIO, F ;
STEINBERG, TH ;
SILVERSTEIN, SC .
CELL CALCIUM, 1990, 11 (2-3) :57-&
[9]   Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors [J].
Donnelly-Roberts, Diana L. ;
Namovic, Marian T. ;
Han, Ping ;
Jarvis, Michael F. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (07) :1203-1214
[10]  
Faulks M., 2016, WORLD J HEMATOL, V5, P88, DOI DOI 10.5315/WJH.V5.I4.88